Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.

Prenalterol, a beta1 agonist, was given in a single blind acute intravenous study to seven patients with cardiac failure (New York Heart Association class II and III). It was then given in a double blind crossover study of sustained oral prenalterol to six of them. As a result of dose titration stud...

Descripción completa

Detalles Bibliográficos

Publicado en:	Br Heart J
Autores principales:	Currie, P J, Kelly, M J, Middlebrook, K, Federman, J, Sainsbury, E, Ashley, J, Pitt, A
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMJ Publishing Group 1984
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481544/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6326784/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.51.5.530
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!